Tadashi Hiramatsu
Nara Medical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tadashi Hiramatsu.
Urological Research | 1975
Eijiro Okajima; Tadashi Hiramatsu; K. Iriya; Masumi Ijuin; S. Matsushima; K. Yamada
SummaryMale and female Wistar strain rats were given 0.05% N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in their drinking water for 6 weeks and then water without BBN for 18 weeks. Diethylstilboestrol and testosterone were implanted subcutaneously into both intact and gonadectomised animals before or after treatment with BBN to evaluate their effects on the development of bladder tumours. Diethylstilboestrol reduced the incidence of bladder tumours significantly in male rats. The incidence was higher in female rats after spaying and administration of testosterone after BBN treatment, than in the intact female.-These results suggest that diethylstilboestrol inhibits carcinogenesis of the urinary bladder induced by BBN and growth of bladder tumours induced by BBN, in male rats. On the other hand, testosterone seems to stimulate the growth of bladder tumours induced by BBN in female rats.
Cancer Chemotherapy and Pharmacology | 1987
Yoshihiko Hirao; Eigoro Okajima; Soichi Ohara; Seiichiro Ozono; Tadashi Hiramatsu; Koujiro Yoshida; Yamada K; Hideo Aoyama; Masayoshi Hashimoto; Shuji Watanabe
SummaryA total of 130 primary cases with superficial bladder cancer were entered in the prospective randomized group study. The prophylactic treatments compared consisted in intravesical instillation of adriamycin (20 mg/40 ml or 30 mg/30 ml), mitomycin C (20 mg/40 ml) or thio-TEPA (30 mg/30 ml), and noninstillation treatments with etretinate or tegafur; control patients were also studied. All agents were administered for 2 years. Recurrences were significantly suppressed in the instillation groups compared with control and non-instillation groups. Significant suppression of recurrence was observed in stage 1 or grade 2 disease treated with prophylactic instillation administered over the first 24 months of a 48-month observation period. These results may indicate the clinical usefulness of prophylactic instillation, but the long-term effect of intravesical instillation is still uncertain. A long-term follow-up study is therefore necessary.
Urological Research | 1973
Eijiro Okajima; Tadashi Hiramatsu; Motomiya Y; T. Kondo; Yoshihiko Hirao
SummaryThe effects of chronic mechanical stimulation induced by glass balls or paraffin balls on precursor lesions of the urinary bladder of male Wistar strain rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in the drinking water were studied.When foreign bodies were present in the bladder, proliferative lesions of the urinary bladder epithelium were found even without administration of carcinogen. When the foreign bodies were implanted into the urinary bladder and then rats were given BBN in the drinking water for the first 4 weeks of the experimental period, a high incidence of tumors of the urinary bladder was observed. The incidence of tumors induced by BBN was increased by the presence of glass balls or paraffin balls in the urinary bladder.These results clearly show that foreign bodies in the urinary bladder have a significant effect in promoting carcinogenesis of the urinary bladder in rats.
Cancer Chemotherapy and Pharmacology | 1994
Yoshihiko Hirao; Seiichiro Ozono; Hitoshi Momose; Okajima E; Tadashi Hiramatsu; Koujiro Yoshida; Shoji Fukushima; Yasuo Ohashi
The preliminary results of a multi-institutional prospective randomized study of the prophylaxis of superficial bladder cancer using epirubicin (protocol NUORG SBT-003) are reported. The subjects were 129 patients with untreated superficial bladder cancer (≦T1b, ≦G2) who were randomized into 2 groups: a transurethral resection (TUR)-alone group (63 patients) and a TUR+intravesical epirubicin (20 mg/40 ml, 30 times/2 years) group (66 patients). The nonrecurrence rate observed in the epirubicin group was significantly higher than that seen in the control group. To unify the pathological diagnosis, a central pathology laboratory (CPL) was set up for extramural review. The correspondence of the pathological diagnosis of TUR-Bt specimens between the CPL and the local pathology laboratory (LPL) was 70.5% in grading and 51.9% in staging. There was a tendency for overdiagnosis by the LPL for both the grade and the stage of tumors. However, differing interpretations by pathologists seem to exert little influence on the nonrecurrence rate at interim analysis. Further observation will be necessary to clarify the prophylactic efficacy of low-dose, long-term periodic intravesical epirubicin instillation and the influence of the disagreement in pathological findings between the CPL and the LPL on the analysis of the results.
Cancer Research | 1981
Eigoro Okajima; Tadashi Hiramatsu; Kazuya Hirao; Masumi Ijuin; Yoshihiko Hirao; Katsuhiro Babaya; Shoichiro Ikuma; Sochi Ohara; Shiomi T; Takashi Hijioka; Hajime Ohishi
GANN Japanese Journal of Cancer Research | 1971
Eigoro Okajima; Tadashi Hiramatsu; Motomiya Y; Kazuyuki Iriya; Masumi Ijuin; Nobuyuki Ito
Acta Oncologica | 1990
Seiichiro Ozono; Akio Iwai; Katsuhiro Babaya; Tadashi Hiramatsu; Koujiro Yoshida; Yamada K; Yoshihiko Hirao; Hideo Aoyama; Soichi Ohara; Eijiro Okajima
The Japanese Journal of Urology | 2006
Makito Miyake; Kenji Takashima; Tadashi Hiramatsu; Kazuya Hirao
Japanese Journal of Clinical Oncology | 1992
Yoshinori Nakagawa; Seiichiro Ozono; Yoshihiko Hirao; Yoshiteru Kaneko; Soichi Ohara; Masahito Yoshii; Kojiro Yoshida; Shuji Watanabe; Tadashi Hiramatsu; Yamada K; Eigoro Okajima
The Japanese Journal of Urology | 1973
Tadashi Hiramatsu; Eigoro Okajima; Motomiya Y; Iriya K; Ijuin M